Display options
Cite
Crook JM, Wallace G, Tomaskovic-Crook E. The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy. Expert Rev Neurother. 2015;15(3):295-304doi: 10.1586/14737175.2015.1013096.
Crook, J. M., Wallace, G., & Tomaskovic-Crook, E. (2015). The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy. Expert review of neurotherapeutics, 15(3), 295-304. https://doi.org/10.1586/14737175.2015.1013096
Crook, Jeremy Micah, et al. "The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy." Expert review of neurotherapeutics vol. 15,3 (2015): 295-304. doi: https://doi.org/10.1586/14737175.2015.1013096
Crook JM, Wallace G, Tomaskovic-Crook E. The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy. Expert Rev Neurother. 2015 Mar;15(3):295-304. doi: 10.1586/14737175.2015.1013096. Epub 2015 Feb 09. PMID: 25664599.
Copy Download .nbib Format: NLM
Share it on

Expert Rev Neurother. 2015 Mar;15(3):295-304. doi: 10.1586/14737175.2015.1013096. Epub 2015 Feb 09.

The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy.

Expert review of neurotherapeutics

Jeremy Micah Crook, Gordon Wallace, Eva Tomaskovic-Crook

Affiliations

  1. ARC Centre of Excellence for Electromaterials Science, Intelligent Polymer Research Institute, AIIM Facility, Innovation Campus, University of Wollongong, Squires Way, Fairy Meadow, New South Wales 2519, Australia.

PMID: 25664599 DOI: 10.1586/14737175.2015.1013096

Abstract

There is an urgent need for new and advanced approaches to modeling the pathological mechanisms of complex human neurological disorders. This is underscored by the decline in pharmaceutical research and development efficiency resulting in a relative decrease in new drug launches in the last several decades. Induced pluripotent stem cells represent a new tool to overcome many of the shortcomings of conventional methods, enabling live human neural cell modeling of complex conditions relating to aberrant neurodevelopment, such as schizophrenia, epilepsy and autism as well as age-associated neurodegeneration. This review considers the current status of induced pluripotent stem cell-based modeling of neurological disorders, canvassing proven and putative advantages, current constraints, and future prospects of next-generation culture systems for biomedical research and translation.

Keywords: biomaterials; drug screening; induced pluripotent stem cells; modeling; neurological disorders; regenerative medicine; therapy; tissue engineering

MeSH terms

Publication Types